20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T39210 | PDE4-IN-4 | PDE4-IN-4 | |
PDE4-IN-4 is a compound acting as both a potent M3 antagonist (p IC 50 = 10.2) and a PDE4 inhibitor (p IC 50 = 8.8), designed for inhalation-based treatment of pulmonary diseases. | |||
T40356 | PDE4-IN-3 | PDE4-IN-3 | |
PDE4-IN-3 is a newly developed oral compound that acts as a potent inhibitor of the enzyme phosphodiesterase 4 (PDE4), displaying a high affinity for inhibition with an IC50 value of 4.2 nM. | |||
T10028 | PDE4 inhibitor intermediate 1 | Others | |
PDE4 inhibitor intermediate 1 is a PDE4 inhibitor synthesis intermediate. | |||
T60934 | PDE4-IN-9 | ||
PDE4-IN-9 (Compound 5j) is a potent PDE4 inhibitor. In vitro enzyme assay, the IC 50 value of PDE4-IN-9 against PDE4 is 1.4 μM which is lower than 2.0 μM of parent rolipram. PDE4-IN-9 also shows good in vivo activity in ... | |||
T60346 | PDE4-IN-10 | ||
PDE4-IN-10 (compound 7a) is a potent inhibitor of PDE4, with an IC 50 of 7.01 μM for PDE4B. PDE4-IN-10 exhibits selectivity, microsomal stability, inhibition of TNF-α and no major toxicities in vitro [1]. | |||
T61295 | PDE4-IN-5 | ||
PDE4-IN-5 (compound 33a) is a highly potent and selective inhibitor of the enzyme PDE4, with an IC50 value of 3.1 nM. It exhibits excellent skin permeability and its binding mechanism has been extensively characterized. ... | |||
T62969 | PDE4-IN-6 | ||
PDE4-IN-6 is a safe, potent and moderately selective inhibitor of PDE4, acting on PDE4B (IC50: 0.125 μM) and PDE4D (IC50: 0.43 μM). PDE4-IN-6 is able to down-regulate TNF-α and IL-6 expression levels, exhibits anti-infla... | |||
T79618 | M3/PDE4 modulator-1 | ||
M3/PDE4 Modulator-1 (compound 10f) serves as a bifunctional entity functioning both as an M3 mAChR antagonist and a PDE4 inhibitor. When administered intravenously at concentrations ranging from 10 to 1000 nM/kg, this co... | |||
T79538 | PDE4-IN-13 | ||
PDE4-IN-13 is a phosphodiesterase 4 (PDE4) inhibitor exhibiting anti-inflammatory and antioxidant activities, with an half maximal inhibitory concentration (IC50) value of 1.56 μM. It is used in the research of chronic o... | |||
T63912 | PDE4-IN-12 | ||
PDE4-IN-12 is a potent and safe PDE4 ubiquitous inhibitor that acts on PDE4 (IC50: 3.5 nM, SI: 2.71) and PDE7 (IC50: 15 nM, SI: 4.27). | |||
T60920 | PDE4-IN-8 | ||
PDE4-IN-8 (Example 5) is a potent Phosphodiesterase 4 (PDE4) inhibitor. The IC50 value of PDE4-IN-8 for PDE4B2 is 0.93 nM. However, PDE4-IN-8 has little effect on IL13, IL4, and IFNy with IC50 values of 4.04 nM, 36.33 nM... | |||
T79624 | PDE4-IN-14 | ||
PDE4-IN-14 (Compound 1) serves as an inhibitor of phosphodiesterase 4 (PDE4), applicable in research concerning diseases associated with PDE4, including inflammatory and immune disorders, cancer, and metabolic diseases [... | |||
T61208 | PDE4-IN-11 | ||
PDE4-IN-11 is a potent phosphodiesterase isoenzyme 4 (PDE4) inhibitor, exhibiting remarkable bronchodilatory and anti-inflammatory characteristics. It is specifically designed for studying obstructive or inflammatory air... | |||
T61620 | AChE/PDE4-IN-1 | ||
AChE/PDE4-IN-1 (compound 12c) is a highly effective and specific dual inhibitor of PDE4 and AChE, with IC50 values of 0.28 μM and 1.88 μM for AChE and PDE4D, respectively. This compound demonstrates notable potential in ... | |||
T27172 | Difamilast | PDE | |
Difamilast is an inhibitor of phosphodiesterase IV. | |||
T25376 | Ensifentrine | Ensifentrina,Ensifentrinum | PDE |
Ensifentrine (Ensifentrinum) is a PDE3/4 inhibitor, although its affinity for PDE3(IC50: 0.4 nM) is 3,440 times higher than that for PDE4(IC50: 1479 nM), that is under clinical development for the treatment of asthma and... | |||
T27475 | GSK356278 | GSK-356278,GSK 356278 | PDE |
GSK356278 is an effective and selective inhibitor of phosphodiesterase 4 (PDE4), with pIC50s of 8.6, 8.8, and 8.7 for human PDE4A, PDE4B, and PDE4D, respectively. GSK356278 has anti-inflammatory, anxiolytic, and cognitio... | |||
T7954 | YM976 | PDE | |
YM976 is an orally active PDE4 inhibitor (IC50:2.2 nM) | |||
T39341 | FCPR03 | PDE | |
FCPR03 is a selective inhibitor of phosphodiesterase 4 (PDE4) with IC50s of 31 nM, 47 nM, and 60 nM for PDE4B1, PDE4D7, and PDE4 catalytic domain, respectively. FCPR03 has neuroprotective, anti-inflammatory, and antidepr... | |||
T6445 | Cilomilast | SB-207499,Ariflo | PDE |
Cilomilast (SB-207499) is a potent PDE4 inhibitor with IC50 of about 110 nM, has anti-inflammatory activity and low central nervous system activity. Phase 3. |